DexCom, Inc. (DXCM)
66.33
+0.71
(+1.08%)
USD |
NASDAQ |
Dec 09, 16:00
66.32
-0.01
(-0.02%)
Pre-Market: 08:19
DexCom EPS Diluted (Quarterly): 0.7035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| BioLife Solutions, Inc. | 0.0127 |
| Boston Scientific Corp. | 0.5048 |
| Insulet Corp. | 1.240 |
| Eli Lilly & Co. | 6.211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 283.80M |
| Revenue (Quarterly) | 1.209B |
| Total Expenses (Quarterly) | 925.50M |
| Enterprise Value | 25.12B |
| Gross Profit Margin (Quarterly) | 61.80% |
| Profit Margin (Quarterly) | 23.47% |
| Earnings Yield | 2.71% |
| Operating Earnings Yield | 2.88% |
| Normalized Earnings Yield | 2.709 |